AQR Capital Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Buy |
80,614
+1,537
| +2% | +$6.15K | ﹤0.01% | 2835 |
|
|
2025
Q1 | $72K | Buy |
+79,077
| New | +$72K | ﹤0.01% | 3059 |
|
|
2024
Q3 | – | Sell |
-10,807
| Closed | -$48.2K | – | 2822 |
|
|
2024
Q2 | $48.2K | Sell |
10,807
-16,909
| -61% | -$75.4K | ﹤0.01% | 2545 |
|
|
2024
Q1 | $212K | Sell |
27,716
-18,197
| -40% | -$139K | ﹤0.01% | 2241 |
|
|
2023
Q4 | $196K | Buy |
45,913
+26,169
| +133% | +$111K | ﹤0.01% | 2221 |
|
|
2023
Q3 | $82.9K | Buy |
+19,744
| New | +$82.9K | ﹤0.01% | 2246 |
|